Today’s podcast covers my conversation with Jill Sisco, president of the Acromegaly Community, about the recent meetings with the Food and Drug Administration (FDA), the US governmental entity responsible for approving new medications. Our conversation focuses on the original meeting held in 2021 and a recent listening session where the AC provided additional feedback to the FDA.
Podcasts
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
A new drug for acromegaly: an insider’s look at the clinical trial
Music Composed and Produced by, MusicWorksFoundry(TM) (ASCAP). All Rights Reserved.
A Conversation with Acromegaly Patient Advocates
Music Composed and Produced by, MusicWorksFoundry(TM) (ASCAP). All Rights Reserved.
Pregnancy and acromegaly
Acromegaly: what to do with medical treatment during pregnancy and the options available today.
Podcast: Living with Hypopituitarism
Music Composed and Produced by, MusicWorksFoundry(TM) (ASCAP). All Rights Reserved.
Cushing’s disease and syndrome: The evolving story of hypercortisolism
The critical need for early diagnosis: a chat with Dr. Javier Salvador
Cortisol levels after Cushing’s surgery
An informal discussion of Cushing’s disease issues from cases, articles, and experiences with patients.
The Road to MYCAPSSA: A Conversation with Dr. Bill Ludlam
Follow ups: Why are they so critical?
Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.
Inquiries
Interesting inquiries prompted by the questions patients leave in their health portals.
A pituitary patient’s experience with COVID-19
A compelling, detailed account of a pituitary patient’s experience with COVID-19 everyone should listen. As the virus takes hold in what is undoubtedly the worst phase of this pandemic, we urge you to follow all
Telemedicine and COVID-19, insights from our survey
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings